Abstract
Economic evaluation is a conglomerate of methods that aim to make explicit the costs and consequences of competing healthcare programmes, and the interconnections between them, so that different interventions can be compared in terms of their value-for-money. In this chapter we outline the main building blocks of health economic evaluation, we explain the differences between the prevailing techniques and we discuss their application in the context of mental health promotion and mental illness prevention.
This is a preview of subscription content, log in via an institution to check access.
References
Brazier, J.E., Ratcliffe, J., Salomon, J. (2007). Measuring and valuing health benefits for economic evaluation. Oxford: Oxford University Press.
Cerri, K. H., Knapp, M., & Fernandez, J. L. (2014). Decision making by NICE: examining the influences of evidence, process and context. Health Economics, Policy & Law, 9, 119–141. doi:10.1017/S1744133113000030.
Chisholm, D., Healey, A., & Knapp, M. (1997). QALYs and mental health care. Social Psychiatry and Psychiatric Epidemiology, 32, 68–75.
Clement, F.M., Harris, A., Li, J.J. (2009). Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada. Journal of the American Medical Association, 302, 1437–43. doi:10.1001/jama.2009.1409.
Cohen, J., Neumann, P., & Weinstein, M. (2008). Does preventive care save money? Health economics and the presidential candidates. New England Journal of Medicine, 358, 661–663. doi:10.1056/NEJMp0708558.
Dakin, H., Devlin, N., & Feng, Y. (2014). The influence of cost-effectiveness and other factors on nice decisions. Health Economics, 24, 1256–1271.
Dolan, P. (2000). The measurement of health related quality of life for use in resource allocation decisions in health care. In: A. Culyer, J. Newhouse, (Eds.) Handbook of health economics (pp. 1724–48). New York: Elsevier.
Dolan, P., & Olsen, J. (2002). Distributing health care: economic and ethical issues. Oxford: Oxford University Press.
Drummond, M., & McGuire, A. (2001). Economic evaluation in health care: merging theory with practice. Oxford: Oxford University Press.
Drummond, M., Sculpher, M.J., Torrance, G.W., O’Brien, B., & Stoddard, G. (2005). Methods for the economic evaluation of health care programmes (Vol. 3). Oxford: Oxford University Press.
Gold, M. R., Siegel, J. E., & Russell, L. B. (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press.
Hausman, D. (2015). Valuing health: wellbeing, freedom and suffering. Oxford: Oxford University.
Kaplan, R. (1995). Utility assessment for estimating quality-adjusted life years. In: F. Sloan (Ed.) Valuing health care: costs, benefits, and effectiveness of pharmaceuticals and other medical technologies (pp. 31–6). New York: Cambridge University Press.
Knapp, M., & Iemmi, V. (2016). Chapter 2: mental health. In R. Scheffler (Ed.), World scientific handbook of global health economics and public policy. New York: World Scientific.
Knapp, M., Mcdaid, D., & Parsonage, M. (2011). Mental health promotion and prevention: the economic case (p. 2011). London: LSE.
Luyten, J., & Beutels, P. (2009). Costing infectious disease outbreaks for economic evaluation: a review for hepatitis A. Pharmacoeconomics, 27(5), 379–389.
Luyten, J., & Henderson, C. (2017). Cost-effectiveness analysis. In D. Razzouk & M. Kayo (Eds.), Mental health economics: The costs and benefits of psychiatric care. New York: Springer.
Luyten, J., Naci, H., & Knapp, M. (2016). Economic evaluation of mental health interventions: an introduction to cost-utility analysis. Evidence-Based Mental Health. doi:10.1136/eb-2016-102354.
McIntosh, E., Clarke, P., Frew, E., & Louviere, J. (2010). Applied methods of cost-benefit analysis in health care. Oxford: Oxford Unversity Press.
Mulhern, B., Mukuria, C., & Barkham, M. (2014). Using generic preference-based measures in mental health: psychometric validity of the EQ-5D and SF-6D. British Journal of Psychiatry, 205(3), 236–243.
O’Brien, B., & Viramontes, J. L. (1994). Willingness to pay: a valid and reliable measure of health state preference? Medical Decision Making, 14, 289–297.
Pauly, M. V. (1995). Valuing health care benefits in money terms. In F. Sloan (Ed.), Valuing health care: costs, benefits, and effectiveness of pharmaceuticals and other medical technologies. New York: Cambridge University Press.
Thomas, C. M., & Morris, S. (2003). Cost of depression among adults in England in 2000. British Journal of Psychiatry, 183, 514–519.
Weinstein, M.C., Torrance G., McGuire, A. (2009). QALYs: the basics. Value in Health, 12(Suppl 1):S5–9. doi:10.1111/j.1524-4733.2009.00515.x.
Weisbrod, B., Test, M. A., & Stein, L. (1980). An alternative to mental hospital treatment. 2: Economic cost-benefit analysis. Archives of General Psychiatry, 37, 400–405.
WHO. (2013). Investing in mental health: evidence for action. Geneva: World Health Organization.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Luyten, J., Knapp, M. (2017). Economic Evaluation of Mental Health Promotion and Mental Illness Prevention. In: Bährer-Kohler, S., Carod-Artal, F. (eds) Global Mental Health . Springer, Cham. https://doi.org/10.1007/978-3-319-59123-0_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-59123-0_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-59122-3
Online ISBN: 978-3-319-59123-0
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)